Header Logo

Connection

SUSAN BLANEY to Matrix Metalloproteinases

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Matrix Metalloproteinases.
SUSAN BLANEY
Connection Strength
0.068
Matrix Metalloproteinases
  1. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatr Blood Cancer. 2007 Sep; 49(3):352-7.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.